Helus Pharma: Millennium Management reports 1.4% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Helus Pharma Inc. (HELP) is the subject of an amended Schedule 13G reporting beneficial ownership as of September 30, 2026. Integrated Core Strategies (US) LLC reported 688,622 common shares, or 0.9%, with shared voting and dispositive power. Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander each reported 1,018,972 common shares, or 1.4%, also with shared voting and dispositive power.
The statement says securities reported for Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander are held by entities subject to voting control and investment discretion of the named management parties. It says the report alone is not an admission of beneficial ownership by those three.
Key Figures
Key Terms
beneficially owned regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.